These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration. Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861 [TBL] [Abstract][Full Text] [Related]
8. [Skeletal muscle MRI of lower limbs in patients with facioscapulohumeral dystrophy]. Ma MM; Song J; Zhang JW; Gao L; Pang M; Li G; Fu J Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(9):675-679. PubMed ID: 30831616 [No Abstract] [Full Text] [Related]
9. Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy. Veltsista D; Chroni E Acta Neurol Scand; 2021 Aug; 144(2):216-220. PubMed ID: 33844852 [TBL] [Abstract][Full Text] [Related]
13. Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. Jordan B; Eger K; Koesling S; Zierz S J Neurol; 2011 May; 258(5):866-73. PubMed ID: 21165637 [TBL] [Abstract][Full Text] [Related]
14. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. Kan HE; Klomp DW; Wohlgemuth M; van Loosbroek-Wagemans I; van Engelen BG; Padberg GW; Heerschap A NMR Biomed; 2010 Jul; 23(6):563-8. PubMed ID: 20175146 [TBL] [Abstract][Full Text] [Related]
15. Correlation between muscle involvement, phenotype and D4Z4 fragment size in facioscapulohumeral muscular dystrophy. Wang CH; Leung M; Liang WC; Hsieh TJ; Chen TH; Jong YJ Neuromuscul Disord; 2012 Apr; 22(4):331-8. PubMed ID: 22153988 [TBL] [Abstract][Full Text] [Related]
16. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study. Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014 [TBL] [Abstract][Full Text] [Related]
17. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy. Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533 [TBL] [Abstract][Full Text] [Related]
18. Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1. Lareau-Trudel E; Le Troter A; Ghattas B; Pouget J; Attarian S; Bendahan D; Salort-Campana E PLoS One; 2015; 10(7):e0132717. PubMed ID: 26181385 [TBL] [Abstract][Full Text] [Related]
19. Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy. Tasca G; Monforte M; Corbi M; Granata G; Lucchetti D; Sgambato A; Ricci E Mol Neurobiol; 2018 Apr; 55(4):2959-2966. PubMed ID: 28456937 [TBL] [Abstract][Full Text] [Related]